Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DEPO

Depomed (DEPO) Stock Price, News & Analysis

Depomed logo

About Depomed Stock (NASDAQ:DEPO)

Advanced Chart

Key Stats

Today's Range
$7.09
$7.42
50-Day Range
N/A
52-Week Range
$4.31
$9.48
Volume
940,193 shs
Average Volume
1.30 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DEPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Depomed and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DEPO Stock News Headlines

Pfizer: Investor Activism Is Not The Solution
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel
Why DepoMed (DEPO) Stock Is Gaining Today
Opioid Litigants Get Boost From Senate Report
See More Headlines

DEPO Stock Analysis - Frequently Asked Questions

Depomed, Inc. (NASDAQ:DEPO) released its quarterly earnings data on Wednesday, August, 8th. The specialty pharmaceutical company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.03. The business's revenue was down 37.0% on a year-over-year basis.

Company Calendar

Last Earnings
8/08/2018
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:DEPO
CIK
1005201
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Optionable
Beta
N/A
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:DEPO) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners